Advertisement

Browse Subject Areas

?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

< Back to Article

Economic evaluation of finotonlimab plus bevacizumab as first-line therapy for advanced hepatocellular carcinoma

Table 2

Parameter distribution of survival curve in two groups.

Table 2

doi: https://doi.org/10.1371/journal.pone.0349044.t002